SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis-Reference-Cited by-同舟云学术

SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis

Published:2023-02 Issue: Volume:555 Page:216046
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Deng Shanshan,Banerjee Souvik,Chen Hao,Pochampally Satyanarayana,Wang Yuxi,Yun Mi-Kyung,White Stephen W.,Parmar Keyur,Meibohm Bernd,Hartman Kelli L.,Wu Zhongzhi,Miller Duane D.,Li Wei^ORCID

Funder

National Institutes of Health

National Cancer Institute

Middle Tennessee State University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference59 articles.

1. Microtubules as a target for anticancer drugs;Jordan;Nat. Rev. Cancer,2004

2. Microtubule-targeting drugs: more than antimitotics;Kaul;J. Nat. Prod.,2019

3. Rescuing microtubules from the brink of catastrophe: CLASPs lead the way;Lawrence;Curr. Opin. Cell Biol.,2019

4. Tubulin islands containing slowly hydrolyzable GTP analogs regulate the mechanism and kinetics of microtubule depolymerization;Bollinger;Sci. Rep.,2020

5. The tubulin code and its role in controlling microtubule properties and functions;Janke;Nat. Rev. Mol. Cell Biol.,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer;Cancer Letters;2024-08

2. Paclitaxel in colon cancer management: from conventional chemotherapy to advanced nanocarrier delivery systems;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-11

3. DDB2 promotes melanoma cell growth by transcriptionally regulating the expression of KMT2A and predicts a poor prognosis;The FASEB Journal;2024-06-11

4. Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer;2024-05-23

5. A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study;Cancer Letters;2024-03